Clinical Publications

Innovation in
Health Tech

Clinical Publications

SR. NO.NAME OF PUBLISHED ARTICLE LINKSJOURNAL AND YEAR OF PUBLICATION NUMBER OF PATIENTS STUDY DESIGNFOLLOW-UPFIRST AUTHOR
Total Publications= 319
DIAGNOSTICS (Total = 3 articles)
ABFIND COVID-19 Neutralizing Antibody Rapid Test-Clinical Publication (Total = 1 articles)
Original Research Article (1)
OR 01

A prospective, single-center study to evaluate the clinical performance of Meril ABFind in individuals vaccinated against Covid-19

Know MoremedRxiv (Preprint) (2022)(2024) 62 Patients Single centre, prospective study- Jayanti Shastri, India
EXIMO™ Blood Glucose Monitoring System-Clinical Publication (Total = 1 articles)
Original Research Article (1)
OR 01

A post-marketing surveillance study to evaluate performance of the EXIMO™ blood glucose monitoring system

Know MoreJournal of Clinical and Diagnostic Research (2017)(2024) 1005 Patients Non-randomized, single-center, post-marketing study- Sonia R. Chandnani, India
CelQuant 360™ Automated Haematology Analyser-Clinical Publication (Total = 1 articles)
Original Research Article (1)
OR 01

Comparison between haematological parameters by the Merilyzer Celquant 360™ automated haematology analyser and Sysmex XP-100 haematology analyser with them manual methods

-European Journal of Biomedical and Pharmaceutical Sciences (2018)(2024)
CARDIOVASCULAR (Total = 283 articles)
BioMime™ Aura Sirolimus Coronary Eluting Stent System-Clinical Publications (Total = 2 articles)
Original Research Article (1)
OR 01

Endovascular reconstruction of popliteal and infrapopliteal arteries for limb salvage and wound healing in Patients with critical limb ischemia-A retrospective analysis

Know MoreIndian Heart Journal (2016)(2024) 34 Patients Retrospective analysis3 Months Uday B. Khanolkar, India
Case Report (1)
OR 01

Multiple coronary microfistulas between left anterior descending artery and left ventricle following myocardial infarction

Know MoreHeart India (2017)(2024) 1 Patient -Post-procedural Sulaiman S, India
Evermine50™ EES-Drug Eluting Stent-Clinical Publications (Total = 13 articles)
Original Research Articles (6)
OR 01

Clinical outcomes of world’s thinnest (50μm) strut biodegradable polymer coated everolimus eluting coronary stent system in real-world Patients

Know MoreCardiology Research (2018)(2024) 251 Patients Prospective, single-arm, single-center, post marketing study6 Months Suresh V. Patted, India
OR 02

Clinical safety and efficacy of world’s thinnest (50μm), very long (>40 mm) everolimus eluting stent among real world Patients

Know MoreAmerican Journal of Cardiovascular Disease (2020)(2024) 711 Patients Prospective, observational study1 Year Santosh Kumar Sinha, India
OR 03

Clinical outcomes of ultrathin strut biodegradable polymer coated everolimus eluting stent in Patients with coronary artery disease

Know MoreARYA Atherosclerosis (2020)(2024) 171 Patients Retrospective study, single-arm, all-comers, single-center study1 Year Suresh V. Patted, India
OR 04

Procedural safety and outcome of ultrathin strut stents (<60 μm) in the management of very long coronary artery stenosis (>30 mm)-A retrospective real-world study

Know MoreAmerican Journal of Cardiovascular Disease (2020)(2024) 65 out of 156 Patients Retrospective analysis, observational study8.4 ± 13.9 months mean follow up Soumya Patra, India
OR 05

Clinical safety and performance of the world’s thinnest strut Evermine50™ Everolimus-eluting stent: A 24-month follow-up of Evermine50 EES-1 study

Know MoreAsiaIntervention (2024)(2024) 118 Patients Prospective, single-arm, multi-center study2 Years Sivaprasad K, India
OR 06

Safety and efficacy of Evermine50 Everolimus-eluting coronary stent system in patients with native coronary artery lesions: Three-year outcomes from a single-center

Know MoreJournal of Cardiovascular and Thoracic Research (2025)(2024) 251 Patients Prospective, post-marketing, single-center study3 years Suresh V Patted, India
Editorial (2)
OR 01

Biodegradable polymer Evermine50™ everolimus eluting coronary stent system with ultrathin (50μm) strut

Know MoreIntegrative Clinical Medicine (2018)(2024) - -- Suresh V. Patted, India
OR 02

Less is more: a new “thin-king” for DES?

Know More-(2024) - -- Azfar G. Zaman, United Kingdom
Case Series (1)
OR 01

Device embolization during trans-radial percutaneous coronary intervention: Various approaches.A case series

Know MoreIHJ Cardiovascular Case Reports (2021)(2024) 3 Patients -- Nagamani Alur Chikkabasavaiah, India
Abstracts (4)
OR 01

Clinical outcomes of ultrathin strut biodegradable polymer coated everolimus-eluting coronary stent system in treatment of patient with de novo coronary artery lesions

Know MoreEuroIntervention (2018)(2024) 171 Patients Single-arm, single-center, non-randomized study1 Year Suresh V. Patted, India
OR 02

Initial experience with ultrathin strut biodegradable polymer-coated everolimus-eluting coronary stent in coronary artery disease Patients

Know MoreJournal of the American College of Cardiology (2018)(2024) 110 Patients Prospective, non-randomized, multi-center study6 Months K. Sivaprasad, India
OR 03

1-year clinical outcomes after percutaneous coronary intervention with biodegradable polymer ultra-thin strut everolimus-eluting coronary stent system

Know MoreJournal of the American College of Cardiology (2019)(2024) 251 Patients Prospective, single-arm, single-center, real-world study1 Year Suresh V. Patted, India
OR 04

One-year clinical outcomes of ultrathin strut everolimus eluting coronary system (50µm) for treatment of patient with de novo coronary artery lesions

Know MoreAsiaIntervention (2019)(2024) 171 Patients Retrospective, single-arm, observational study1 Year Suresh V. Patted, India
BioMime Branch™ Sirolimus Eluting Coronary Side Branch Stent System-Clinical Publication (Total = 2 articles)
Original Research Article (1)
OR 01

Coronary Bifurcation Lesion Treatment with the BioMime™ Branch Sirolimus-Eluting Coronary Side-Branch Stent System: A Single-Center Experience

Know MoreCardiovascular Revascularization Medicine (2024)(2024) 58 Patients Retrospective, single-center study18 Months Antonio L. Bartorelli, Italy
Abstract (1)
OR 01

BioMime™ Branch-1: a randomized comparison of sirolimus-eluting coronary side branch stent systems and everolimus-eluting stent systems to assess safety and performance in Patients with de novo coronary bifurcation lesions

Know MoreEuroIntervention (2020)(2024) 18 out of 24 Patients Prospective, active-control, open-label, multi-center, randomized clinical trial6 Months Sethuraman Selvamani, India
BioMime™ Morph Sirolimus Eluting Tapered Coronary Stent System- Clinical Publications (Total = 34 articles)
Original Research Articles (14)
OR 01

First experience with the use of extra-long (40 to 60 mm) sirolimus-eluting stents in Patients with diffuse long
coronary lesions

Know MoreKardilogiya (2017)(2024) 85 Patients Prospective, single-centre study1 Year Yu G Matchin, Russia
OR 02

First report of the use of long-tapered sirolimus-eluting coronary stent for the treatment of chronic total occlusion with the hybrid algorithm

Know MoreCatheterization Cardiovascular Interventions (2018)(2024) 49 out of 100 Patients Observational retrospective study303 ± 179 Days CarlZivelonghi, The Netherlands
OR 03

Clinical outcomes of novel long-tapered sirolimus-eluting coronary stent system in real-world Patients with long diffused de novo coronary lesions

Know MoreCadiology Research (2018)(2024) 362 Patients Retrospective, non-randomized, multi-centre study1 Year Suresh V. Patted, India
OR 04

Comparison of clinical outcomes between very long stents and overlapping stents for the treatment of diffuse coronary disease in real clinical practice

Know MoreCardiovascular Revascularization Medicine (2018)(2024) 628 Patients Single-centre, retrospective, observational studyMedian follow-up of 20 months Alfonso Jurado Román, Spain
OR 05

Feasibility of implanting 50-60 mm-tapered drug eluting stents in chronic total occlusions

Know MoreCardiovascular Revascularization Medicine (2019)(2024) 51 out of 54 Patients Retrospective, single-arm studyA median follow-up of 330 (149-551) days Gema Miñana, Spain
OR 06

Clinical experience with 12-month follow-up in Patients after implantation of a novel long tapered sirolimus drug-eluting stent

Know MoreAdvances in Interventional Cardiology (2019)(2024) 32 Patients Prospective clinical cohort study1 Year Jakub Podolec, Poland
OR 07

Real-world experience with a tapered biodegradable polymer-coated sirolimus-eluting stent in Patients with long coronary artery stenosis

Know MoreCardiology Research (2020)(2024) 272 Patients Prospective, observational, and multi-centre study1 Year Alessandro Lupi, Italy
OR 08

Feasibility and outcomes of left main to branch vessel PCI with novel tapered coronary stent in a tertiary care center: a real-world experience

Know MoreCardiovascular and Hematological Disorders Drug Targets (2021)(2024) 41 Patients Prospective, non-randomised, single-centre studyMedian follow-up 20 months T.R.Raghu, India
OR 09

One-year outcomes of novel BioMime™ Morph tapered stent in long and multiple coronary artery lesions

Know MoreAnatolian Journal of Cardiology (2021)(2024) 172 Patients Observational, retrospective, single-center study1 Year Yash Paul Sharma, India
OR 10

Percutaneous Intervention in Diffuse Coronary Disease: Overlapping Versus Single Very Long Stent Technique. Results From the OVERLONG Registry

Know MoreAngiology (2021)(2024) 678 Patients Observational, retrospective, and single-center studyMedian follow-up 31 months Martín Negreira-Caamaño, Spain
OR 11

Real-world experience with a 60 mm long stent in the setting of primary percutaneous coronary intervention

Know MoreHeart Views (2022)(2024) 88 Patients Retrospective, observational analysis1 Year Babu Thevan, Kingdom of Bahrain
OR 12

Long-Term Safety and Performance of BioMime™ Morph Sirolimus-Eluting Coronary Stent System for Very Long Coronary Lesions

Know MoreCardiology Research (2024)(2024) 88 Patients Prospective, single-center, observational, real-world, post-marketing surveillance study 3 Years Suresh V. Patted, India
OR 13

Clinical outcomes of the BioMime™ Morph Coronary stent systme for long (30 to ≤ 56 mm length) coronary lesions: Three years follow-up of the Morpheus Global Registry.

Know MoreCardiovascular Revasecularization Medicine (2025)(2024) 565 Patients Prospective, single-arm, multicenter , observational, real-world registry3 Years Pierfrancesco Agostoni, Belgium
OR 14

Long-Term Safety and Performance of BioMime Morph Sirolimus-Eluting
Coronary Stent System for Very Long Coronary Lesions in Real-world
Settings: Morph India study

Know MoreAsiaIntervention (2025)(2024) 448 Patients Prospective, multi-center, single-arm, real-world, post-marketing Surveillance study3 Years Deepak Davidson, India
Abstracts (8)
OR 01

Long term outcome after revascularization of long coronary artery lesions with very long or overlapping stents. Insights from the propensity score matched registry

Know MoreJournal of the American College of Cardiology (2017)(2024) 123 out of 377 Patients Prospective, multi-centre registry2 Years Piotr Buszman, Poland
OR 02

Experience of the management of complex long lesion by Indigenous BioMime™ Morph tapering stents

Know MoreJournal of the American College of Cardiology (2017)(2024) 52 Patients Prospective, observational study9 Months Manotosh Panja, India
OR 03

Real World Experience of the BioMime™ Morph tapered stent in a Tertiary Care Hospital

Know MoreJournal of the American College of Cardiology (2018)(2024) 122 Patients Retrospective observational study26 Months Sanjai Pattu Valappil, India
OR 04

Multicenter clinical outcomes of hybrid tapered sirolimus eluting coronary stent system with biodegradable polymer in long diffuse de novo coronary artery lesions

Know MoreEuroIntervention (2018)(2024) 362 Patients Retrospective, multi-center, non-randomized study6 Months Suresh V.Patted, India
OR 05

Initial experience with the novel BioMime™ Morph 40-60 mm long sirolimus-eluting tapered stent in long coronary lesions

Know MoreEuroIntervention (2018)(2024) 55 Patients Prospective, single-centre study200 ± 50 Days Anirban Choudhary, United Kingdom
OR 06

First Experience with very long coronary drug eluting stent

Know MoreJournal of the American College of Cardiology (2019)(2024) 63 Patients Retrospective study1-3 Months Farhat Fouladvand, Italy
OR 07

Clinical outcome of the world’s first tapered sirolimus eluting coronary stent system for long coronary lesions: a real-world experience

Know MoreEuroIntervention (2020)(2024) 435 Patients Prospective, single-arm, multi-centre, real-world study1 Year Deepak Davidson, India
OR 08

Longitudinal stent deformation detected on coronary CT in the novel BioMime™ 60mm long sirolimus-eluting tapered stent

Know MoreEuroIntervention (2020)(2024) 20 Patients Prospective, single-centre study6-9 Months Silvia Homs, Spain
Case Reports (9)
OR 01

A report of successful procedural, clinical, and angiographic outcomes with a tapered stent of a patient in naturally tapered coronary vessel

Know MoreJournal of Clinical and Diagnostic Research (2017)(2024) 1 Patient -1 Year Rajendra Kumar Premchand, India
OR 02

First in Poland, unique 60-mm long single drug eluting tapered stent implantation in a patient with unstable angina

Know MorePolish Heart Journal (2017)(2024) 1 Patient -Post-procedural Jakub Podolec, Poland
OR 03

Intravascular ultrasonography guided 60-mm long drug eluting tapered stent implantation in a long-calcified lesion in a patient with stable coronary artery disease

Know MoreAdvances in International Cardiology (2017)(2024) 1 Patient -Post-procedural Jakub Podolec, Poland
OR 04

Management of long complex CTO in LCX by indigenous BioMime™ Morph tapering stents from Meril

Know MoreJournal of the American College of Cardiology (2017)(2024) 1 Patient -Post-procedural Manotosh Panja, India
OR 05

The perfect storm

Know MoreJournal of the American College of Cardiology (2017)(2024) 1 Patient -Post-procedural Jayakhanthan Kolanthaivelu, Malaysia
OR 06

Tapered stents in long diffusely diseased coronary arteries-our experience

Know MoreJournal of the American College of Cardiology (2017)(2024) 1 Patient -2 Years T.R. Raghu, India
OR 07

Acute stent loss and its retrieval of a long, tapering Morph stent in a tortuous, calcified lesion

Know MoreCardiology Research (2018)(2024) 1 Patient -Post-procedural Santosh Kumar Sinha, India
OR 08

Successful treatment of tandem calcific right coronary artery stenoses with 50 mm tapered BioMime™ Morph stent guided by intravascular ultra sound and rotablation using a sheath less guide via the radial access

Know MoreIHJ Cardiovascular Case Report (2019)(2024) 1 Patient -1 Year Baskar Sekar, United Kingdom
OR 09

Use of BioMime™ Morph stent in treating left main triple vessel disease: a case report

Know MoreThe Egyptian Heart Journal (2020)(2024) 1 Patient -6 Months Yash Paul Sharma, India
Short Report (1)
OR 01

Initial Experience with the novel BioMime 60mm-long sirolimus-eluting tapered stent system in long coronary lesions

Know MoreEuroIntervention (2017)(2024) 50 Patients Prospective clinical cohort studyMedian follow-up 275 Days Ernesto Valero, Spain
Commentary (1)
OR 01

Innovative DES technologies from Meril

Know MoreMinerva Cardiology and Angiology (2015)(2024) - -- Sanjeev Bhatt, India
Editorial (1)
OR 01

Treatment of long coronary lesions with single stent: BioMime Morph sirolimus-eluting tapered coronary stent system

Know MoreHeart India (2018)(2024) - -- Suresh V. Patted, India
MeRes100™ Sirolimus Eluting BioResorbable Vascular Scaffold System- Clinical Publications (Total = 21 articles)
Original Research Articles (6)
OR 01

First-in-human evaluation of a novel poly-L-lactide based sirolimus-eluting bioresorbable vascular scaffold for the
treatment of de novo native coronary artery lesions: MeRes-1 trial

Know MoreEuroIntervention (2017)(2024) 108 Patients Prospective, multi-center, single-arm study1 Year Ashok Seth, India
OR 02

Pharmacokinetic study of sirolimus-eluting bioresorbable vascular scaffold system for treatment of de novo native coronary lesions: a sub-study of MeRes-1 trial

Know MoreCardiology Research (2018)(2024) 10 Patients Prospective, single-arm, open-label pilot study90 days Praveen Chandra, India
OR 03

Three-year clinical and two-year multimodality imaging outcomes of a thin-strut sirolimus-eluting bioresorbable vascular scaffold: MeRes-1 trial

Know MoreEuroIntervention (2019)(2024) 108 Patients Prospective, multi-center, single-arm, open-label clinical trial3 Years Ashok Seth, India
OR 04

Imaging and two-year clinical outcomes of thin strut sirolimus-eluting bioresorbable vascular scaffold:
the MeRes-1 extend trial

Know MoreCatheterization and Cardiovascular Interventions (2020)(2024) 64 Patients Prospective, multi-centre, single-arm, open-label study2 Years Alexandre Abizaid, Brazil
OR 05

A real-world experience with a thin-strut Bioresorbable vascular scaffold system: a single-centre study

Know MoreAsiaIntervention (2025)(2024) 86 Patients Retrospective, single-centre study1 Year Puneet K. Verma, India
OR 06

Two-year longitudinal evaluation of a second-generation thin-strut sirolimus-eluting bioresorbable coronary scaffold with hybrid cell design in porcine coronary arteries

Know MoreJournal of Interventional Cardiology (2018)(2024) Preclinical, controlled, comparative, and longitudinal study45, 90, 180 days, 1 year, and 2 years Pawel Gasior, Poland
Abstracts (9)
OR 01

Quantitative angiographic analysis in Patients with de novo native coronary artery lesions treated with novel poly-L-lactide based sirolimus-eluting bioresorbable vascular scaffold: MeRes-1 Trial

Know MoreEuropean Heart Journal (2017)(2024) 108 Patients First-in-manAngiographic follow-up at 6-and 24 months Ricardo Costa, Brazil
OR 02

First-in-human evaluation of a novel poly-L-lactide based sirolimus-eluting bioresorbable vascular scaffold for the treatment of de novo native coronary artery lesions: MeRes-1 trial

Know MoreJournal of the American College of Cardiology (2017)(2024) 108 Patients Prospective, multi-centre, first-in-human studyAngiographic follow-up at 6-months, clinical follow-up at 12 months Ashok Seth, India
OR 03

Favorable outcomes for systemic pharmacokinetic study of sirolimus-eluting bioresorbable vascular scaffold system in treating de novo native coronary artery lesion: A sub study of MeRes-1 Trial

Know MoreJournal of the American College of Cardiology (2017)(2024) 10 Patients Prospective, multi-centre study90 Days Ashok Seth, India
OR 04

Real world performance of the novel MeRes100™

Know MoreJournal of the American College of Cardiology (2017)(2024) 34 Patients (41 MeRes100 implanted) Prospective, single-centre, registry9 Months Marcos Ortega, Ecuador
OR 05

Two-year clinical and imaging outcomes of thin strut sirolimus-eluting bioresorbable vascular scaffolds in de novo coronary artery lesions: the MeRes-1 trial

Know MoreJournal of the American College of Cardiology (2018)(2024) 108 Patients Prospective, multi-centre, single-arm study2 Years Ashok Seth, India
OR 06

Real world follow-up one year of the novel MeRes100

Know MoreJournal of the American College of Cardiology (2018)(2024) 65 Patients (81 MeRes100 implanted) Prospective, single-centre registry1 Year and OCT at 9 months Marcos Ortega, Ecuador
OR 07

Implantation of thin-strut sirolimus-eluting bioresorbable vascular scaffold in Patients with de novo coronary artery lesions: 2-year clinical and 6-month imaging outcomes of the MeRes-1 extend trial

Know MoreJournal of the American College of Cardiology (2019)(2024) 64 Patients Multi-centre, prospective, single-arm studyImaging follow-up at 6 months and clinical follow-up at 2 years Alexandre Abizaid, Brazil
OR 08

Clinical and imaging outcomes of thin-strut sirolimus eluting BRS in Patients with de novo coronary artery lesions: the MeRes-1 extend trial

Know MoreEuroIntervention (2020)(2024) 64 Patients Prospective, multi-centre, single-arm studyAngiographic follow-up at 6 months and clinical follow-up upto 24 months Alexandre Abizaid, Brazil
OR 09

The MeRes-1 Extend trial: 2-year clinical and 6-month imaging outcomes of thin-strut sirolimus-eluting BRS in Patients with de novo coronary artery lesions

Know MoreJournal of the American College of Cardiology (2020)(2024) 64 Patients Prospective, multi-centre, single-arm studyImaging follow-up at 6 months and clinical follow-up at 2 years Alexandre Abizaid, Brazil
Review Articles (3)
OR 01

Bioresorbable scaffold The emerging reality and future directions

Know MoreCirculation Research (2017)(2024) - -- Yohei Sotomi, Netherlands
OR 02

Bioresorbable coronary scaffolds: deployment tips and tricks and the future of the technology

Know MoreMethodist DeBakey Cardiovascular Journal (2018)(2024) - -- J. Ribamar Costa, Brazil
OR 03

Fully bioresorbable vascular scaffolds: Lessons learned and future directions

Know MoreNature Reviews Cardiology (2019)(2024) - -- Hiroyuki Jinnouchi, United States of America
Book Chapter (1)
OR 01

MeRes100™ -A sirolimus eluting bioresorbable vascular
scaffold system

Know MoreIn Bioresorbable Scaffolds (2017)(2024) - -- Ashok Seth, India
Editorial/ Editorial Commentary (2)
OR 01

A fresh look at bioresorbable scaffold technology: Intuition pumps

Know MoreIndian Heart Journal (2017)(2024) - -- Sundeep Mishra, India
OR 02

Can the vanishing stent reappear? Fix the technique, or fix the device?

Know MoreJournal of the American College of Cardiology (2017)(2024) - -- Spencer B. King, USA
Mozec™ Rx PTCA Balloon Dilation Catheter- Clinical Publications (Total = 6 articles)
Original Research Articles (3)
OR 01

Complex coronary interventions with the novel Mozec™ CTO balloon: The Mozart registry

Know MoreClinical Medicine Insights: Cardiology (2015)(2024) 41 Patients Prospective non- randomized, single-arm registry1 Year Alessandro Lupi, Italy
OR 02

Clinical outcomes of a non-compliant balloon dilatation catheter: Mozec™ NC study

Know MoreInternational Journal of Environmental Research and Public Health (2022)(2024) 57 of 140 Patients Post-marketing, single-centre, single-arm, retrospective study10.40 ± 0.26 months Akshyaya Pradhan, India
OR 03

Safety and Performance of the MOZEC Sirolimus-Eluting
Coronary Balloon in the Treatment of Stenotic Coronary Artery Lesions: A Real-world, Multicenter, Post-marketing

Know MoreCardiology Research (2025)(2024) 141 Patients Prospective, single-arm, multi-centre, real-world, post-marketing surveillance study24 Months Rajendra Kumar Premchand Jain,India
Abstract (1)
OR 01

How to make a deal with distal left main coronary artery type a trifurcation lesion

Know MoreJournal of the American College of Cardiology (2017)(2024) 1 Patient -- Yusra Pintaningrum, Indonesia
Review Article (1)
OR 01

Drug-coated balloons: technologies and clinical applications

Know MoreCurrent Pharmaceutical Design (2018)(2024) - -- Huiying Ang, Singapore
Case Report (1)
OR 01

Persistent stent thrombosis in a patient with non-ST segment elevation myocardial infarction and mild COVID-19

Know MoreJournal of Coronary Artery Disease (2022)(2024) 1 Patient -Procedural Details Mehmet Rasih Sonsoz, Turkey
Metafor™ Sirolimus Eluting Coronary Stent System-Clinical Publications (Total = 5 articles)
Original Research Articles (3)
OR 01

One-year clinical outcomes of biodegradable polymer coated sirolimus-eluting coronary stent system in Patients with coronary artery disease

Know MoreWorld Journal of Cardiovascular Diseases (2017)(2024) 251 Patients Retrospective, single-center, observational, post-marketing study1 Year Sridhar Kasturi, India
OR 02

Safety and performance of sirolimus-eluting coronary stent system with biodegradable polymer: a retrospective analysis in real-world patient population

Know MoreWorld Journal of Cardiovascular Diseases (2017)(2024) 127 Patients Retrospective, non-randomized, single-center study3.6 ± 0.6 Years Vithala Surya Prakasa Rao, India
OR 03

Twelve-month clinical outcomes of biodegradable polymer coated sirolimus-eluting coronary stent in real-world Patients: a single-center experience

Know MoreIndian Heart Journal (2021)(2024) 141 Patients Retrospective, single-centre, post-marketing, observational study1 Year Pankaj Jariwala, India
Abstracts (2)
OR 01

One-year clinical outcomes of biodegradable polymer coated sirolimus-eluting coronary stent system in Patients with coronary artery disease

Know MoreJournal of the American College of Cardiology: Cardiovascular interventions (2017)(2024) 251 Patients Retrospective, single center, observational, post-marketing study1 Year Shridhar Kasturi, India
OR 02

Safety and clinical performance of biodegradable polymer coated sirolimus-eluting coronary stent in real-world Patients

Know MoreEuroIntervention (2020)(2024) 141 Patients Observational, single-center, post-marketing, retrospective study1 Year Pankaj Jariwala, India
NexGen™ Bare Metal Stent-Clinical Publication (Total = 1 articles)
Abstract (1)
OR 01

Evaluation of safety and efficacy of NexGen-an ultrathin strut and hybrid cell design cobalt-chromium bare metal stent implanted in a real-life patient population-the Polish NexGen™ Registry

Know MoreAdvances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej (2016)(2024) 383 Patients A prospective, multi-center registry1 Year Krzysztof Milewski, Poland
Osum™ Cobalt Chromium Coronary Stent System-Clinical Publication (Total = 1 articles)
Original Research Article (1)
OR 01

Clinical safety and performance of novel ultra-thin strut cobalt chromium bare metal stent implanted in real-world Patients with coronary artery disease

Know MoreInternational Journal of Current Research (2018)(2024) 467 Patients Observational, non-randomized, retrospective, single-arm study2 Years Mahesh Basarge, India
Dafodil™ Pericardial Bioprosthesis-Clinical Publications (Total = 2 articles)
Original Research Articles (2)
OR 01

Clinical outcomes and hemodynamic performance of Dafodil™ aortic and mitral pericardial bioprosthesis: 1-year results from Dafodil-1 first-in-human trial

Know MoreJournal of Cardiothoracic Surgery (2020)(2024) 60 Patients First-in-human, prospective, single-arm, and multi-center trial1 Year C.S. Hiremath, India
OR 02

Three-year Outcomes of Surgical Valve Replacement with Dafodil™ Pericardial Bioprosthesis: Dafodil™-1 Trial

Know MoreFrontiers in Cardiovascular Medicine (2024)(2024) 136 Patients First-in-human, prospective, multi-center study3 Years C.S. Hiremath, India
CREDENCE™ BtK Sirolimus Eluting Bioresorbable Peripheral Scaffold System-Clinical Publication (Total = 1 articles)
Abstract (1)
OR 01

12-month clinical outcomes of sirolimus-eluting bioresorbable peripheral scaffold system following percutaneous transluminal angioplasty of below-the-knee arteries in Patients with critical limb ischaemia: the CREDENCE™ BtK-1 study

Know MoreEuroIntervention (2020)(2024) 30 Patients First-in-man, prospective, multi-centre and open-label study1 Year Vimal Someshwar, India
Menox™ Liquid Embolic System-Clinical Publications (Total = 7 articles)
Original Research Article (2)
OR 01

Intermixed dimethyl-sulfoxide based non adhesive liquid embolic agents delivered serially via the same micro catheter for cerebral AVM treatment

Know MoreAmerican Journal of Neuroradiology (2020)(2024) 16 Patients Single-centre, prospective studyAngiographic mean follow-up of 5.1 months Alexander Sirakov, Bulgaria
OR 02

Comparison of a Novel Liquid Embolic System with Commonly Used Embolic Agents in the Endovascular Treatment of Intracranial Dural Arteriovenous Fistulas: A Single-Center Experience

Know MoreJournal of Clinical Medicine (2024)(2024) 11 out of 19 Patients Single center, retrospective study12 Months Zarko Nedeljkovic, Serbia
Case Report (2)
OR 01

Endovascular treatment of a post-traumatic pseudoaneurysm arising from a ruptured posterior tibial artery with Menox™ A case report

Know MoreRadiology Case Reports (2021)(2024) 1 Patient -6 Months Christina Aslanidi, Greece
OR 02

Embolization Using the Novel Menox Liquid Embolic System for Arteriovenous Fistulas: A Case Report

Know MoreJournal of Clinical and Medical Image (2023)(2024) 1 Patient -6 Months Audrius Sirvinskas, Lithuania
Case Series (2)
OR 01

Extending endovascular embolization to type A spinal peri-medullary arteriovenous fistula using liquid embolic agent: technical nuances, challenges and initial outcomes

Know MoreWorld Neurosurgery (2018)(2024) 3 Cases -- Virender Malik, India
OR 02

Initial experience with the new ethylene vinyl alcohol copolymer based liquid embolic agent Menox™ in the endovascular treatment of cerebral arteriovenous malformations

Know MoreJournal of NeuroInterventional Surgery (2018)(2024) 24 Patients Pilot study, retrospective analysis of prospectively collected data6 Months Stanimir Sirakov, Bulgaria
Review Article (1)
OR 01

Glue, Onyx, Squid or PHIL? Liquid Embolic Agents for the Embolization of Cerebral Arteriovenous Malformations and Dural Arteriovenous Fistulas

Know MoreClinical Neuroradiology (2022)(2024) - -- Dominik F. Vollherbst, Germany
Obtura™Vascular Closure Device- Clinical Publication (Total = 1 articles)
Original Research Article (1)
OR 01

Comparing Obtura Vascular Closure Device to Manual Compression for Achieving Hemostasis After Percutaneous Transfemoral Procedures: A Randomized Study

Know MoreJournal of Endovascular Therapy (2024)(2024) 134 out of 268 Patients Prospective, randomized, controlled, multi-center trial3 Months Tom Devasia, India
Mammoth Balloon Catheter-Clinical Publication (Total = 1 articles)
Original Research Articles (1)
OR 01

Performance of the Mammoth Balloon Catheter in Patients with Severe Aortic Valve Stenosis Undergoing Percutaneous Treatment

Know MoreJournal of Clinical Medicine (2024)(2024) 121 Patients Retrospective, single-center cohort analysisPost-procedure Silvia Moscardelli, Italy
BioMime™ Sirolimus Eluting Coronary Stent System-Clinical Publications (Total = 46 articles)
Original Research Articles (11)
OR 01

First-in-human evaluation of the novel BioMime sirolimus-eluting coronary stent with bioabsorbable polymer for the treatment of single de novo lesions located in native coronary vesselsresults from the meriT-1 trial

Know MoreEuroIntervention (2013)(2024) 30 Patients Prospective, non-randomized, single-arm, single-centre, first-in-human study1 Year Sameer Dani, India
OR 02

Late angiographic and clinical outcomes of the novel BioMime
sirolimus-eluting coronary stent with ultra-thin cobalt-chromium platform
and biodegradable polymer for the treatment of diseased coronary
vessels: results from the prospective, multi-centre meriT-2 clinical trial

Know MoreAsiaIntervention (2016)(2024) 250 Patients Prospective, non randomized, single-arm, multicentre, phase II clinical study1 Year Ashok Seth, India
OR 03

One-year outcomes of a BioMime sirolimus-eluting coronary stent system
with a biodegradable polymer in allcomers coronary artery disease
patients: The meriT-3 study

Know MoreIndian Heart Journal (2016)(2024) 1161 Patients Retrospective, multi-centre study1 Year Rajendra Kumar Jain, India
OR 04

Randomized comparison of biodegradable polymer ultra-thin
Sirolimus-eluting stent versus a durable polymer everolimus-eluting
coronary stent in patients with de novo native coronary artery lesions:
the meriT-V trial 

Know MoreEuroIntervention (2018)(2024) 256 Patients Prospective, multicentre, randomized, open-label, activecontrolled, and non-inferiority trial9 Months Alexandre Abizaid, Brazil
OR 05

Single long stents versus overlapping multiple stents in the
management of very long coronary lesions: comparisons of procedures
and clinical outcomes

Know MoreThe Journal of Tehran University Heart Center (2019) (2024) 124 out of 1709 Patients Historical cohort study1 Year Alireza Amirzadegan, Iran
OR 06

Clinical outcomes of biodegradable polymer sirolimus-eluting stent in
coronary artery lesions patients: a retrospective analysis

Know MoreEC Cardiology (2020)(2024) 73 Patients Retrospective, single-center , nonrandomized and observational studyMean follow-up: 1.68±0.58 years Binu Thankappan Gomathy, India
OR 07

Clinical follow-up of long non-tapered sirolimus-eluting coronary stent in
real- world patients with de novo lesions: The Billar registry

Know MoreREC Interventional Cardiology (2022) (2024) 696 Patients Prospective, nonrandomized, multi-centre study1 Year Enric Domingo Ribas, Spain
OR 08

A Randomized Controlled Trial Comparing BioMime SirolimusEluting Stent with Everolimus-Eluting Stent: Two-Year Outcomes of the meriT-V Trial

Know MoreCardiology Research (2023)(2024) 252 out of 256 Patients Prospective, multi-center, randomized, active-controlled , non-inferiority trial2 Years Alexandre Abizaid, Brazil
OR 09

Long-Term Assessment of Thin-Strut BioMime Coronary Stent System in
Real- World Population at Single-Center: A Retrospective Observational Study

Know MoreCardiology Research (2023) (2024) 1188 patients Retrospective, observational, single-center, post- marketing clinical follow-up study4 years Girish Meennahalli Palleda, India
OR 10

Real-world evidence of BioMime sirolimus-eluting stent in obstructive
coronary artery disease: meriT -2 trial

Know MoreAsiaIntervention (2024)(2024) 250 Patients Prospective, single-arm, multicentre study5 Years Upendra Kaul, India
OR 11

Safety and Efficacy of BioMime Sirolimus-eluting Stent System in
All-comers: Real-world Population with Coronary Artery Stenosis: MILES
Global Registry 

Know MoreCardiology Research Journal (2024)(2024) 771 Patients Post-marketing, multicenter, single-arm, observational clinical registry2 Years Martin Hudec, Slovakia
Meta Analysis (2)
OR 01

Newer generation ultra-thin strut drug- eluting stents versus older
second- generation thicker strut drug-eluting stents for coronary artery
disease: a meta-analysis of randomized trials

Know MoreCirculation (2018)(2024) 170 out of 11,658 Patients 170 out of 11,658 Patients1 Year Sripal Bangalore, USA
OR 02

Long-term follow-up after ultrathin vs. conventional 2ndgeneration drugeluting stents: a systematic review and meta-analysis of randomized controlled trials

Know MoreEuropean Heart Journal (2021)(2024) 170 out of 20,701 Patients Meta-analysis of 16 trials that randomized 20,701 patientsMean follow-up: 2.5 Years Mahesh V. Madhavan, USA
Abstracts (16)
OR 01

Moving towards biomimicrydevelopment of novel BioMime sirolimus eluting coronary stent system

Know MoreThe American Journal of Cardiology (2011)(2024) 250 Patients Single-arm, multi-center trial1-month clinical outcome and 8-month angiographic outcomes Ashok Seth, India
OR 02

Impact of the new BioMime sirolimus-eluting stent in complex patients of daily practice-preliminary results of the meriT-2 study

Know MoreJournal of the American College of Cardiology (2012)(2024) 242 Patients Prospective, nonrandomized, multi-center study8 months angiographic and 1-year clinical follow- up Erlon de Abreu Silva, Brazil
OR 03

First-in-human evaluation of a novel sirolimus-eluting stent with a
bioabsorbable polymer for the treatment of single, de novo, noncomplex coronary lesions

Know MoreJournal of the American College of Cardiology (2012)(2024) 30 Patients Prospective, nonrandomized, single-arm, single-center study8-month angiographic and 1-year clinical follow- up Erlon de Abreu Silva, Brazil
OR 04

Efficacy of the novel BioMime sirolimus-eluting stents with a
biodegradable polymer in the treatment of de novo coronary
lesions: an angiographic sub-analysis of the combined meriT-1 and
meriT-2 prospective clinical trials

Know MoreJournal of the American College of Cardiology (2013)(2024) 280 Patients An angiographic sub-analysis of combined meriT-1 and meriT-2 prospective clinical trialsAngiographic analysis at 8 months of both studies Ricardo A. Costa, Brazil
OR 05

How to make a deal with distal left main coronary artery type A trifurcation lesion

Know MoreJournal of the American College of Cardiology (2017)(2024) 1 Patient Case studyProcedural Details Yusra Pintaningrum , Indonesia
OR 06

Three-year clinical outcomes of BioMime sirolimus-eluting coronary
stent system with a biodegradable polymer in coronary artery disease
patients: a long-term follow-up of the meriT-2 study

Know MoreJournal of the American College of Cardiology (2017)(2024) 250 Patients Prospective, multi-center study3 Years Ashok Seth, India
OR 07

Efficacy and safety of an ultrathin strut sirolimus eluting stent with
biodegradable polymer in all-comers patients undergoing coronary
intervention 

Know MoreEuropean Heart Journal Supplement (2018)(2024) 588 Patients Prospective, non-randomized, multi- centre, open label, observational registry9 Months Ian Menown, United Kingdom
OR 08

Single long stent vs. overlapping multiple stents in the management of
very long coronary lesions: comparison of success rates and oneyear clinical outcomes

Know MoreEuroIntervention (2018)(2024) 124 out of 1709 Patients Historical cohort studyMean follow-up: 441 ± 361 Days A. Amirzadega, Iran
OR 09

Twelve-months clinical outcomes comparing biodegradable polymer
sirolimus-eluting stent versus durable polymer everolimus-eluting coronary stents in patients with de novo native
coronary artery lesions: the meriT-V randomized trial

Know MoreJournal of the American College of Cardiology (2018)(2024) 170 out of 256 Patients Prospective, multicentre, randomized, active controlled, noninferiority clinical trial1 Year Alexandre Abizaid, Brazil
OR 10

Safety and efficacy of sirolimus-eluting stent system in all-comers real-world population with coronary artery stenosis: the MILES-GLOBAL study

Know MoreJournal of the American College of Cardiology (2019)(2024) 520 Patients Multi-centre, prospective, single-arm, open-label study1 Year Martin Hudec, Slovakia
OR 11

One-year clinical outcomes in patients implanted with biodegradable
polymer coated ultra-thin strut sirolimus-eluting coronary stent
system for the treatment of very long (≥40mm) lesions

Know MoreJournal of the American College of Cardiology (2019)(2024) 216 Patients Retrospective single-center study1 Year Mohit Gupta, India
OR 12

Clinical outcomes from real-world patients treated with
biodegradable polymer coatedultrathin-strut sirolimus-eluting
coronary stent system- BioMimeGBPR

Know MoreEuroIntervention (2020) (2024) 1003 Patients Retrospective, single- centre study2 Years Vishal Batra, India
OR 13

Safety and performance of the biodegradable polymer-coated ultrathin
strut sirolimus-eluting coronary stent system for very long lesions: 12-month experience in real-world clinical practice 

Know MoreEuroIntervention (2020)(2024) 216 Patients Retrospective, single-centre study2 Years Vivek Jindal, India
OR 14

Safety and efficacy of sirolimuseluting stent system in all-comers realworld population with coronary artery stenosis: the MILES-GLOBAL study

Know MoreEuroIntervention (2020)(2024) 520 Patients Multi-center, prospective, single-arm, open-label study1 Year Martin Hudec, Slovakia
OR 15

Primary efficacy and safety outcomesof a sirolimus-eluting thin-strut
coronary stent system in all-comer patients undergoing PCI: the MILESUK registry

-EuroIntervention (2020)(2024) 752 Patients Prospective, non-randomized, multi-center, open-label, observationa l registry9 Months Ian Menown, United Kingdom
OR 16

Strut coverage of the ultrathin BioMime stent: a single-centre
experience from the MILES-UK registry

Know MoreEuroIntervention (2020)(2024) 28 out of 111 Patients Prospective, post-marketi ng OCT analysis3 Months Sudipta Chattopadhyay, United Kingdom
Review Article (5)
OR 01

Moving towards Biomimicry-the development of the novel BioMime sirolimus-eluting coronary stent system 

Know MoreEuropean Cardiology Review (2010) (2024) - -- Ashok Seth, India
OR 02

Advantages of novel BioMime sirolimus eluting coronary stent system. Moving towards biomimicry

Know MoreMinerva Cardioangiologica (2012)(2024) - -- Upendra Kaul, India
OR 03

Innovative DES technologies from Meril

Know MoreMinerva Cardioangiologica (2015)(2024) - -- Sanjeev Bhatt, India
OR 04

Novel bioabsorbable polymer and polymer-free metallic drugeluting stents

Know MoreJournal of Cardiology (2018) (2024) - -- Jason Nogic, Australia
OR 05

Ultrathin struts drug-eluting stents: a state-of-the-art review

Know MoreJournal of Personalized Medicine (2022)(2024) - -- Attilio Leone, Belgium
Case Reports (8)
OR 01

IVUS guided stenting in moderate looking proximal coronary lesion

Know MoreJournal of Indian College of Cardiology (2013)(2024) 1 Patient -Post-procedural Aniket Puri, India
OR 02

A percutaneous coronary intervention complication: coronary perforation

Know MoreJournal of Turgut Ozal Medical Center (2013)(2024) 1 Patient -Procedural Details Abdulmek Yildiz, Turkey
OR 03

In-situ intra procedure left main coronary artery thrombosis

Know MoreJournal of the American College of Cardiology (2014)(2024) 1 Patient -Procedural Details Puneet Verma, India
OR 04

Ostial circumflex stenting through left main-LAD stent: a challenge of
access in tortuous complex circumflex anatomy

Know MoreJournal of the American College of Cardiology (2015)(2024) 1 Patient -Procedural Details Gurunath P. Parale, India
OR 05

Chronic total occlusion intervention with no-flow tackled successfully

Know MoreJournal of the American College of Cardiology (2015) (2024) 1 Patient -Post-procedural Arvind Kumar Kandoria, India
OR 06

Inter-coronary communication in chronic total occlusion: in search of recognition 

Know MoreIndian Heart Journal (2016)(2024) 1 Patient -6 Months Mohit Gupta, India
OR 07

Bifurcation stenting. It’s easy. That’s what I thought

Know MoreJournal of the American College of Cardiology (2016)(2024) 1 Patient Post-procedural Mohan Ramachandran, Malaysia
OR 08

Cuspal dissection of aorta during percutaneous coronary intervention
to left anterior descending artery managed successfully

Know MoreIHJ Cardiovascular Case Reports (2018)(2024) 1 Patient -Post-procedural Shilpa Jayaprakash, India
Editorial Letter (1)
OR 01

Gone long, not wrong: BioMime Morph and a tale of coronary ambition

Know MoreAsiaIntervention (2025)(2024) - -- Ignacio J. Amat-Santos, Spain
Review Report/Scientific Reports (2)
OR 01

BioMime a sirolimus-eluting coronary stent system for the treatment of
patients with de novo coronary lesions- ando-1 report

Know MoreInterventional Cardiology Review, Research, Resources (2011)(2024) 30 Patients Prospective, single-arm, single-cente r study1 Year Clinical Trial Department, Meril Life Sciences, India
OR 02

Comparison of over expansionvcapabilities and thrombogenicity at the
side branch ostia after implantation of our different drug eluting stents

Know MoreNature (2020)(2024) - -- Pawel Gasior, Poland
Commentary (1)
OR 01

Very long stent technology: clinical and practical value

Know MoreFuture Cardiology (2013)(2024) - -- Ian Menown, United Kingdom
Myval™ Transcatheter Heart Valve Replacement-Clinical Publications (Total = 140 articles)
Original Research Articles (46)
OR 01 First-in-human evaluation of a novel balloon-expandable transcatheter heart valve in Patients with severe symptomatic native aortic stenosis: the MyVal-1 studyKnow MoreEuroIntervention (2020)(2024) 30 Patients First-in-human, prospective, multi-center, single-arm, open-label study1 Year Samin K. Sharma, USA
OR 02 Single-center experience of 105 minimalistic transfemoral transcatheter aortic valve replacement and its outcomeKnow MoreIndian Heart Journal (2021)(2024) 105 Patients Single-center, retrospective study30 Days Ravinder Singh Rao, India
OR 03 Quantitative angiographic assessment of aortic regurgitation after transcatheter aortic valve implantation among three balloon-expandable valvesKnow MoreGlobal Heart (2021)(2024) 108 out of 744 Patients Retrospective, multi-center studyPost- implantation aortography Hideyuki Kawashima, Ireland
OR 04

Operator preference and determinants of size selection
when additional intermediate-size aortic transcatheter heart valves are made available (MATCH-BALL Protocol)

Know MoreInternational Journal of Cardiology (2021)(2024) 1115 Patients Retrospective survey- Hideyuki Kawashima, Ireland
OR 05

Early clinical and haemodynamic matched comparison of balloon-expandable valves (MATCH-BALL)

Know MoreHeart (2021)(2024) 130 of 416 Patients Prospective study30 Days Jose R Delgado-Arana, Spain
OR 06 Next-generation balloon-expandable Myval™ transcatheter heart valve in low-risk aortic stenosis PatientsKnow MoreCatheterization and Cardiovascular Interventions (2021)(2024) 100 Patients Retrospective, multi-center registry30 Days Mario Garcia-Gomez, Spain
OR 07 Early multicenter experience of a new balloon-expandable Myval™ transcatheter heart valve in dysfunctional stenosed right ventricular outflow tract conduitsKnow MoreAnnals of Pediatric Cardiology (2021) (2024) 7 Patients Retrospective, multi-centre studyMedian follow-up 16 months Muthukumaran C Sivaprakasam, India
OR 08 Myval™ versus alternative balloon-and self-expandable transcatheter heart valves: A central core lab analysis of conduction disturbancesKnow MoreInternational Journal of Cardiology (2021)(2024) 135 out of 1131 Patients Central corelab analysis, retrospective registry1 Year Santos Martinez S, Spain
OR 09 First experiences with a new balloon-expandable Myval transcatheter aortic valve: a preliminary studyKnow MoreHerz Cardiovascular Diseases (2021) (2024) 25 Patients Retrospective study3 Months Ali Rıza Akyüz, Turkey
OR 10 Safety and efficacy of Myval implantation in Patients with severe bicuspid aortic valve stenosis-a multi-center real world experienceKnow MoreJournal of Clinical Medicine (2022)(2024) 68 Patients Retrospective study30 Days Ahmed Elkoumy, Ireland
OR 11 Feasibility of precise commissural and coronary alignment with balloon-expandable TAVIKnow MoreRevista Española de Cardiología (2022)(2024) 10 Patients Prospective study1 Month Sandra Santos-Martınez, Spain
OR 12 Comparing two-year outcomes of balloon expandable Myval and self- expanding Evolut R in severe aortic valve stenosisKnow MoreInternational Journal of Cardiology (2023) (2024) 58 out of 166 Patients Retrospective, single-center, observational, cohort analysis2 Years Elisabetta Moscarella, Italy
OR 13 Transcatheter aortic valve implantation for severe bicuspid aortic stenosis- 2 years follow up experience from IndiaKnow MoreFrontiers in Cardiovascular Medicine (2022)(2024) 70 BAV Patients of 287 Multi-centre study2 Years Vijay Kumar, India
OR 14 Transcatheter mitral valve-in-valve implantation with the balloon expandable Myval deviceKnow MoreJournal of Clinical Medicine (2022)(2024) 11 Patients Multi-centre, retrospective study6 Months Sara Blasco-Turrión, Spain
OR 15 Short-term outcome after transcatheter aortic valve replacement with a novel balloon-expandable valveKnow MoreNetherlands Heart Journal (2022)(2024) 120 Patients Prospective, single-centre study6 Months Jonathan Halim, The Netherlands
OR 16 Balloon-expandable TAVR bioprostheses: area or perimeter sizing? A prospective pilot studyKnow MoreJournal of Interventional Cardiology (2022)(2024) 60 Patients Prospective, single-centre study1 Year Jonathan Halim, The Netherlands
OR 17 Transcatheter aortic valve implantation: a report on Serbia’s first systematic programKnow MoreFrontiers in Cardiovascular Medicine (2022)(2024) 13 out of 56 Patients Cohort study30 Days Darko Boljevic, Serbia
OR 18 Transcatheter valve-in-valve or valve-in-ring implantation with a novel balloon-expandable device in Patients with bioprosthetic left side heart valves failure:1-year follow-up from a multi-center experienceKnow MoreInternational Journal of Cardiology (2023) (2024) 97 Patients Prospective, multi-centre study1 Year Elisabetta Moscarella, Italy
OR 19 Latest iteration balloon and self-expandable transcatheter valves for severe bicuspid aortic stenosis: The TRITON studyKnow MoreRevista Española de Cardiología (2023)(2024) 122 out of 360 Patients Multi-centre, retrospective registry30 Days Ignacio J Amat-Santos, Spain
OR 20 One-year outcomes after Myval implantation in Patients with bicuspid aortic valve stenosis-a multi-centre real-world experienceKnow MoreJournal of Clinical Medicine (2023)(2024) 62 Patients Retrospective multi-centre study13.5 months median follow-up Ahmed Elkoumy, Ireland
OR 21 Safety and performance parameters of the Myval transcatheter aortic valve bioprosthesis: The SAPPHIRE prospective registryKnow MoreCardiovascular Revascularization Medicine (2023) (2024) 100 Patients Single-arm, prospective registry2 Years Luca Testa, Italy
OR 22 Angiographic quantification of aortic regurgitation following Myval Octacor implantation: Independent core lab adjudicationKnow MoreInternational Journal of Cardiology (2023)(2024) 125 Patients Retrospective, core lab analysis- Ahmed Elkoumy, Ireland
OR 23 Assessing the Novel Myval Balloon-Expandable Valve with the Evolut Valve: A Propensity- Matched StudyKnow MoreJournal of Clinical Medicine (2023)(2024) 120 out of 223 Patients Retrospective, single-center study1 Year Jonathan Halim, The Netherlands
OR 24 Early Outcomes of a Next- Generation Balloon-Expandable Transcatheter Heart Valve – The Myval System: A Single-Center Experience from SerbiaKnow MoreJournal of Cardiology and Cardiovascular Medicine (2023)(2024) 13 Patients Retrospective, single center study30 Days Darko Boljevic, Serbia
OR 25 Clinical outcomes of TAVI with the Myval balloon-expandable valve for non-calcified aortic regurgitationKnow MoreEuroIntervention (2023)(2024) 113 Patients International, multi-center, observational study 1 Year Juan Pablo Sánchez-Luna, Spain
OR 26 Performance of the 32 mm Myval transcatheter heart valve for treatment of aortic stenosis in Patients with extremely large aortic annuli in real- world scenario: first global, multi-centre experienceKnow MoreCatheterization and Cardiovascular Interventions (2023)(2024) 10 Patients Global Retrospective, observational multi-center study30 Days Andreas Holzamer, Germany
OR 27 Transcatheter Aortic Valve Replacement for Pure Native Aortic Valve Regurgitation: The PANTHEON International ProjectKnow MoreJACC: Cardiovascular Interventions (2023)(2024) 40 out of 69 Ballon expandable Patients Retrospective study1 Year Enrico Poletti, Italy
OR 28 Single center experience with the balloon‐expandable Myval transcatheter aortic valve system with the first 100 Patients: 30‐day and 1‐ year follow‐upKnow MoreCatheterization and Cardiovascular Interventions (2023)(2024) 100 Patients Retrospective, single-center study1 Year Balázs Magyari, Hungary
OR 29 Clinical comparison of a novel balloon-expandable versus a self-expanding transcatheter heart valve for the treatment of Patients with severe aortic valve stenosis: the EVAL RegistryKnow MoreJournal of Clinical Medicine (2022)(2024) 58 of 166 Patients Retrospective, single-centre study6 months Monica Barki, Italy
OR 30 Clinical Outcomes Following Transcatheter Mitral Valve-in-Valve Replacement Using a Meril Myval Transcatheter Heart ValveKnow MoreHeart, Lung and Circulation (2023)(2024) 20 Patients Retrospective, observational, single-centre study1 Year Mullasari Ajit Sankardas, India
OR 31 Single-Center Experience with the Balloon Expandable Myval Transcatheter Aortic Valve System in Patients with Bicuspid Anatomy: Procedural and 30-Day Follow-UpKnow MoreJournal of Clinical Medicine (2023)(2024) 52 Patients Retrospective, observational study30 Days Balázs Magyari, Hungary
OR 32 Safety and effectiveness of the novel Myval Octacor transcatheter heart valve in severe, symptomatic aortic valve stenosis – A real world Indian experience (The OCTACOR India Study)Know MoreCardiovascular Revascularization Medicine (2024)(2024) 123 Patients Multi-center, real-world observational registry30 Days John Jose, India
OR 33 Multicenter Experience for Early and Mid-Term Outcome of MyVal Transcatheter Pulmonary Valve ImplantationKnow MorePediatric Cardiology (2024) (2024) 53 Patients Multi-center, observational study360 Days median follow-up Mohamed Al Nasef, Saudi Arabia
OR 34 Clinical outcomes of the Myval transcatheter heart valve system in Patients with severe aortic valve stenosis: a two-year follow-up observational studyKnow MoreArchives of Medical Science (2024)(2024) 207 Patients Multi-centre, registry based, observational study2 Years Teoman Kilic, Turkey
OR 35 LANDMARK trial: Randomised non-inferiority comparison of early outcomes of newer generation Myval THV series with contemporary valves (Sapien and Evolut THV series) in real-world Patients with severe symptomatic native aortic stenosisKnow MoreThe Lancet (2024) (2024) 768 Patients RCT30 Days Andreas Baumbach, UK
OR 36 German Experience with a Novel Balloon-Expandable Heart Valve Prosthesis for Transcatheter Aortic Valve Implantation Outcomes of the MYLAND (MYvaL germAN stuDy) StudyKnow MoreJournal of Clinical Medicine (2024)(2024) 134 Patients Investigator-initiated, multi-center, retrospective, observational study30 Days Timm Ubben, Germany
OR 37 Early Outcomes of Transcatheter Aortic Valve Implantation With Next-generation Balloon-expandable Myval Transcatheter Heart Valve: Single-center Experience From IraqKnow MoreJournal of the Saudi Heart Association (2024)(2024) 100 Patient Prospective single-centre study30 Days Khalid Amber, Iraq
OR 38 Initial experience with the Myval balloon expandable valve in ArgentinaKnow MoreRevista Argentina de Cardioangiología Intervencionista (2024)(2024) 300 Patients Prospective multi-center registryPost-procedure Federico Blanco, Argentina
OR 39 Performance of balloon-expandable transcatheter bioprostheses in inoperable patients with pure aortic regurgitation of a native valve: The BE-PANTHEON international projectKnow MoreCardiovascular Revascularization Medicine (2024)(2024) 41 out of 144 Patients Retrospective study1 year Enrico Poletti, Italy
OR 40

Learning Curve for Starting a Successful Single-Centre TAVR Programme with Multiple Devices: Early and Mid-Term Follow-Up

Know MoreJournal of Clinical Medicine (2024)(2024) 11 out of 122 Patients Retrospective study3 Years Balázs Magyari, Hungary
OR 41

The Myval Balloon-Expandable Transcatheter Heart Valve Implant in Aortic and Mitral Interventions: A Single-Center Experience

Know MoreCureus (2025)(2024) 15 Patients Retrospective single- cohort observational study22 Months Ramesh Patel, India
OR 42

SAPIEN 3 versus Myval transcatheter heart valves for transcatheter aortic valve implantation (COMPARE-TAVI 1): a multicentre, randomised, non-inferiority trial

Know MoreThe Lancet (2025)(2024) 514 out of 1031 Patients "Multicentre, all-comers, randomised, non- inferiority trial"1 Year Christian Juhl Terkelsen, Denmark
OR 43

"Percutaneous Pulmonary Valve Implantation In Native
Right Ventricular Outflow Tract Using Myval™ Without
Pre‐Stenting"

Know MoreHealth Science Reports (2025)(2024) 17 patients Multicenter registry"Immediate results of 30.5 and 32 mm MyVal™ valves implantation" João Luiz Langer Manica, Brazil
OR 44

Immediate and Early Outcomes Following Myval Octacor Transcatheter Heart Valve Implantation for the Treatment of Patients With Severe Aortic Valve Stenosis: The OCTACOR‐EU Study

Know MoreCatheterization and Cardiovascular Interventions (2025)(2024) 252 patients An observational, retrospective, multicenter, investigator‐driven registry30 Days Alfonso Ielasi, Italy
OR 45

Early outcomes of the novel Myval THV series compared to SAPIEN THV series and Evolut THV series in individuals
with severe aortic stenosis 

Know MoreEuroIntervention (2024)(2024) 384 out of 768 Patients Prospective, RCT30 Days Niels van Royen, The Netherlands
OR 46

A new and easy parameter to predict the requirement for permanent pacemaker implantation after transaortic valve
implantation: aortic knob calcification 

Know MoreAdvances in Interventional Cardiology (2024)(2024) 110 out of 180 Patients Retrospective studyPost-procedure Ahmet Özderya, Turkey
Abstracts (14)
OR 01 Evaluation of balloon expandable transcatheter heart valve in the treatment of severe symptomatic native aortic stenosis: the first-in human MyVal-1 studyKnow MoreStructural Heart (2020)(2024) 100 Patients First-in-human, prospective, multi-centre, single-arm study1 Month Ravinder Singh Rao, India
OR 02 Clinical and haemodynamic outcomes of Patients who underwent transcatheter mitral valve-in-valve replacement: one- month resultsKnow MoreThe American Journal of Cardiology (2020)(2024) 10 Patients -1 Month Ravinder Singh Rao, India
OR 03 Implant of Myval transcatheter aortic valve in Patients with severe aortic stenosisKnow MoreStructural Heart (2020)(2024) 5 Patients Prospective study30 days, 6 Months Andrea Janet Robaina Barrios, Venezuela
OR 04 Safety and efficacy of Myval™ transcatheter heart valve for treatment of severe symptomatic aortic stenosis at 30‐daysKnow MoreCatheterization and Cardiovascular Intervention (2020)(2024) 7 Patients Retrospective review1 Month Nayef A. Al Asiri, Saudi Arabia
OR 05 Early single-center experience with Meril’s Myval transcatheter heart valveKnow MoreJACC: Cardiovascular Interventions (2022)(2024) 39 Patients Single-centre, single-arm, open label, prospective registry30 Days Alberto Colella Cervone, Brazil
OR 06 Commissural/Coronary Alignment with the Novel Myval™ Octacor THV-The Octa Align TechniqueKnow MoreJACC: Cardiovascular Interventions (2023)(2024) 30 Patients -- Pruthvi C. Revaiah, Ireland
OR 07

Win Ratio Analysis of the LANDMARK Trial: Myval Transcatheter Heart Valve vs Contemporary Standard Valves (Sapien and Evolut) in Patients With Severe Aortic Stenosis

Know More"JACC: Cardiovascular Interventions (2024)"(2024) 768 Patients "Multicenter, randomized, non-inferiority trial"30 Days Akihiro Tobe, Ireland
OR 08

Comparison of the Self-Expandable Acurate Neo 2 and the New Balloon-Expandable Myval Series Transcatheter Heart Valve at 4-Year Follow-Up

Know More"JACC: Cardiovascular Interventions (2024)"(2024) 401 out of 545 Patients Multicentric analysis4 Years Akash Jain, Spain
OR 09

Predictors of Conduction System Disturbances Resulting in a New Permanent Pacemaker Implantation Within the LANDMARK Trial

Know More"JACC: Cardiovascular Interventions (2024)"(2024) 352 out of 706 Patients Prospective randomized trial30 Days Pieter Smits, The Netherlands
OR 10

Conduction Disturbances and Permanent Pacemaker Implantation After Myval Transcatheter Heart Valve or Contemporary Standard Valves (Sapien and Evolut)
Implantation: Insights From the

Know MoreJACC: Cardiovascular Interventions (2024)(2024) Baseline 757, Before discharge 744, After 30 days 715 (Total 768) Prospective randomized trial30 Days Pieter Smits, The Netherlands
OR 11

Initial Experience With the Myval Balloon-Expandable Transcatheter Heart Valve in Argentina

Know MoreJACC: Cardiovascular Interventions (2024)(2024) 500 Patients Prospective multi-center registry- Federico Blanco Argentina
OR 12

The Current Generation of THV: A Single-Center Propensity Score Match Analysis

Know MoreJACC: Cardiovascular Interventions (2024)(2024) 228 Patients Single-center, propensity-score matching study1 Year Matjaz Bunc, Slovenia
OR 13

“Smart” Analysis of the Landmark Trial - Early Outcomes
With Latest Generation Tavi Valves in Patients With a Small
Aortic Annulus 

Know MoreJACC: Cardiovascular Interventions (2025)(2024) 125 of 245 (Total 768 Patients) RCT30 Days Patrick W. Serruys, Ireland
OR 14

Early Outcomes With Three TAVI Valves (Myval, Sapien, and Evolut Series) in Women - Substudy of Landmark Trial 

Know MoreJACC: Cardiovascular Interventions (2025) (2024) 193 of 369 (Total 768 Patients) RCT30 Days Akihiro Tobe, Ireland
Case Reports (35)
OR 01 Successful transcatheter aortic valve replacement in a kidney allograft patient on rapamycinKnow MoreIndian Journal of Transplantation (2019)(2024) 1 Patient -Procedural Details Aashish Chopra, India
OR 02 First transcatheter pulmonary valve implantation-an Indian made valveKnow MoreIHJ Cardiovascular Case Reports (2020)(2024) 1 Patient -6 Months Muthukumaran Chinnasamy Sivaprakasam, India
OR 03 Simultaneous percutaneous coronary intervention and transcatheter aortic valve implantation in a very high-risk octogenarian patient-what’s ideal time?Know MoreIHJ Cardiovascular Case Reports (2020)(2024) 1 Patient -8 Months Pankaj Jariwala, India
OR 04 Myval™ and mini-chimney stenting to prevent coronary obstruction during full root stent-less aortic valve-in-valve procedureKnow MoreCardiovascular Revascularization Medicine (2020)(2024) 1 Patient -6 Months Alfonso Ielasi, Italy
OR 05 Successful management of left main coronary artery obstruction following transcatheter aortic valve implantationKnow MoreIHJ Cardiovascular Case Reports (2020)(2024) 1 Patient -Procedural Details Viveka Kumar, India
OR 06 Tip-to-base lampoon to prevent left ventricular outflow tract obstruction in a valve-in-ring transcatheter mitral valve replacement: first LAMPOON procedure in turkey and first LAMPOON case for transseptal Myval™ implantationKnow MoreAnatolian Journal of Cardiology (2021)(2024) 1 Patient -1 Month Teoman Kılıç, Turkey
OR 07 Transcatheter tricuspid valve-in-valve implantation with a novel balloon expandable Myval THVKnow MoreThe Annals of Thoracic Surgery (2021)(2024) 1 Patient -1 Month Bilge Duran Karaduman, Turkey
OR 08 First-in-man valve-in-valve with the new balloon-expandable Myval™ transcatheter heart valve in a failed sutureless perceval bioprosthesisKnow MoreJournal of Cardiac Surgery (2021)(2024) 1 Patient -30 Days Igor Belluschi, Italy
OR 09 Transcatheter aortic valve implantation for aortic insuffiency in Patients with left ventricular assistanceKnow MoreGiornale Italiano di Cardiologia (2021)(2024) 1 Patient -Post-procedural Marco B. Ancona, Milan, Italy
OR 10 Pulmonary percutaneous valve implantation in large native right ventricular outflow tract with 32mm Myval transcatheter heart valveKnow MoreCatheterization and Cardiovascular Interventions (2021)(2024) 1 Patient -1 Year Alejandro Rodríguez Ogando, Spain
OR 11 Transcatheter treatment tricuspid regurgitation by valve-in-ring implantation with a novel balloon-expandable Myval™ THVKnow MoreClinical vignette Kardiologia Polska (2022)(2024) 1 Patient -Procedural Details Hüseyin Ayhan, Turkey
OR 12 Transcatheter mitral valve-in-valve replacement transeptally using a novel balloon-expandable deviceKnow MoreJournal of Cardiac Surgery (2022)(2024) 1 Patient -Procedural Details Maria Drakopoulou, Greece
OR 13 Under-deployed TAVI with occluded left-main and severe aortic regurgitation; bailout chimney-in-chimney stenting and aggressive post-dilatation saves the dayKnow MoreClinical Case Reports (2022)(2024) 1 Patient -1 Week Pandula Athauda-arachchi, Sri Lanka
OR 14 Redo-transcatheter aortic valve implantation in a patient at high risk of coronary obstruction due to sinus sequestrationKnow MoreEuropean Heart Journal (2023)(2024) 1 Patient -Post-procedural Ying-Hwa Chen, Taiwan
OR 15 In-series transcatheter aortic valve replacement-in-transcatheter aortic valve replacement: ACURATE neo transcatheter heart valve degeneration successfully managed with Myval, avoiding coronary flow obstruction-a case reportKnow MoreStructural Heart (2023)(2024) 1 Patient -1 Month Joao Felipe Barros de Toledo, Brazil
OR 16 Left ventricular assist device implantation combined with direct transaortic transcatheter valve-in-annular stent implantation after rescue mechanical Bentall procedure, a case reportKnow MoreBMC Journal of Cardiothoracic Surgery (2023)(2024) 1 Patient -Post-procedural Yuriy Pya, Kazakhstan
OR 17 Case report: a novel surgical technique for rapid valve-in-ring implantation into the native aortic annulus during left ventricular assist device implantationKnow MoreFrontiers in Cardiovascular Medicine (2023)(2024) 1 Patient -6 Months Yuriy Pya, Kazakhstan
OR 18 Pulmonary valve replacement in a large and tortuous right ventricle outflow tract with a 32 mm Myval valve under local anesthesia: challenges and technical considerations: a case reportKnow MoreEuropean Heart Journal Case Reports (2023)(2024) 1 Patient -3 Months Ali Houeijeh, France
OR 19 Case report: A complex case of valve-in-valve TAVI and left bundle branch pacing for severe aortic regurgitation with partially corrected type A aortic dissection and low ejection fractionKnow MoreFrontiers in Cardiovascular Medicine (2023)(2024) 1 Patient -1 Year Peter Marko Mihailovič, Slovenia
OR 20 Transcatheter aortic valve implantation for aortic regurgitation in HeartMate II supported patient using Myval THV: a case reportKnow MoreOxford Medical Case Reports (2023)(2024) 1 Patient -1 Year Mohamad Hamieh, Lebanon
OR 21 Technical Aspects for Transcatheter Aortic Valve Replacement with the Novel Balloon-Expandable Myval OctacorKnow MoreJACC: Cardiovascular Intervention (2024)(2024) 1 Patient -Post-procedural Alfonso Ielasi, Italy
OR 22

Case report: Transcatheter tricuspid valve-in-valve implantation using novel balloon-expandable aortic
valve with 1 year follow-up

Know MoreFrontiers in Cardiovascular Medicine (2023)(2024) 5 Patients -1 Year Abdurashi d Mussayev, Kazakhstan
OR 23

Direct aortic TAVI via anterior right mini thoracotomy using 32 mm myval for pure aortic regurgitation

Know MoreJournal of Cardiothoracic Surgery (2024)(2024) 1 Patient Post procedural Firas Aljanadi,UK
OR 24

Coronary alignment by OctaAlign technique using
Myval Octacor transcatheter heart valve in a bicuspid aortic valve 

Know MoreJournal of Cardiovascular Intervention (2024)(2024) 1 Patient -Post procedural Raja Ramesh Nukavarapu, India
OR 25

Transcatheter pulmonary valve implantation with custom-made 35-mm Myval™ transcatheter heart valve 

Know MoreAnnals of Pediatric Cardiology (2024)(2024) 1 Patient -Post procedural Sivasubramanian Ramakrishnan, India
OR 26

Coronary Artery Protection with Chimney Stent in High-Risk Case of Coronary Occlusion in Transcatheter Aortic Valve Implantation

Know MoreJournal of National Heart & Lung Society Nepal (2024)(2024) 1 Patient -Post procedural Chandra Mani Adhikari, Nepal
OR 27

Transcarotid aortic valve implantation using the novel
Myval Octacor valve: First experience in Poland 

Know MorePolish Heart Journal (2024)(2024) 1 Patient -Post procedural Robert Sobczyński, Poland
OR 28

Transcatheter aortic valve implantation using balloon-expandable Myval transcatheter heart valve in a patient with bicuspid aortic valve with low-flow , low-gradient
severe aortic stenosis

Know MoreNepalese Heart Journal (2024)(2024) 1 Patient -Post-procedural Chandra Mani Adhikari Nepal
OR 29

Transcatheter Mitral Valve-in-valve Implantation with
the Balloon-expandable Myval Device 

Know MoreIndian Journal of Clinical Cardiology (2024)(2024) 1 Patient -Post-procedural Suresh Kumar Paidi India
OR 30

Single-stage transcatheter mitral valve in valve implantation and paravalvular leak closure following failure of bioprosthetic valve and cardiogenic shock

Know MoreIHJ Cardiovascular Reports (2024)(2024) 1 Patient -Post-procedural Dhamodaran Kaliyamoorthy India
OR 31

Successful Management of Myval Transcatheter Heart Valve Embolization into Abdominal Aortic Aneurysm During Transcatheter Aortic Valve Replacement

Know MoreThe Texas Heart Institute Journal (2024)(2024) 1 Patient -3 Months Artemio García-Escobar, Spain
OR 32

First Transcatheter Valve-in-Valve Implantation With Myval Octacor Into a Failed Biological Prosthetic Aortic Valve in Serbia

Know MoreCardiology Research (2025)(2024) 1 Patient -6 Months Valentina Balint Jovanovic, Serbia
OR 33

Reflections on transfemoral TAVI in dextrocardia with severe aortic regurgitation: Navigating anatomical complexity, off-label innovation, and future directions

Know MoreInternational Journal of Cardiology Congenital Heart Disease (2025) (2024) 1 Patient -30 Days Pandula Athauda arachchi, Sri Lanka
OR 34

Transcatheter Aortic Valve Replacement in Pure Native
Valve Aortic Regurgitation Using a 35‐mm Balloon
Expandable Myval XXL

Know MoreCatheterization and Cardiovascular Interventions (2025)(2024) 1 Patient -30 Days Jayesh Bhaskaran, India
OR 35

A challenging TAVI-in-TAVI with Balloon expandable
Myval and Chimney Stenting of LMCA 

Know MoreThe Journal of Heart Valve Disease (2025)(2024) 1 Patient - Dr. Dibya Ranjan Behera
Case Series (10)
OR 01 Trans-catheter valve-in-valve implantation with a novel balloon expandable device in Patients with bioprosthetic heart valve failure: A case seriesKnow MoreCardiovascular Revascularization Medicine (2020)(2024) 5 Patients -Postprocedural (Upto 72 hrs) Alfonso Ielasi, Italy
OR 02 First experiences with Myval™ transcatheter heart valve system in the treatment of severe pulmonary regurgitation in native right ventricular outflow tract and conduit dysfunctionKnow MoreCardiology in the Young (2021)(2024) 9 Patients -9.8 months mean follow up Ender Odemis, Turkey
OR 03 Two case reports of transcatheter valve-in-valve implantation of Sapien 3 and MyVal in degenerated biological tricuspid prosthesis valvesKnow MoreEuropean Heart Journal (2022)(2024) 2 Patients -6 Years Rebekka Vibjerg Jensen, Denmark
OR 04 TAVR in a large bicuspid anatomy using the XL-Myval™ 32mmKnow MoreFrontiers in Cardiovascular Medicine (2022)(2024) 3 Patient -30 Days Ahmed Elkoumy, Ireland
OR 05 Transcatheter mitral valve replacement (TMVR) for degenerated mitral valve bioprosthesis-A case seriesKnow MoreIHJ Cardiovascular Case Reports (2023)(2024) 5 Patients -1 Month Viveka Kumar, India
OR 06 Transcatheter Aortic Valve Implantation in Two High-Risk Patients with Low Coronary Ostial Heights Using the Novel Balloon Expandable MyvalTM ValveKnow MoreJournal of Cardiology And Cardiovascular Medicine (2023)(2024) 2 Patients -1 Month Raja Ramesh N, India
OR 07 A new simple technique for stabilizing the guidewire position within the left ventricle during transcatheter mitral valve‐in‐valve implantationKnow MoreCatheterization and Cardiovascular Interventions (2024)(2024) 2 Patients -Post-procedure Kothandam Sivakumar, India
OR 08

Transcatheter aortic valve replacement in patients with a pre-existing prosthetic mitral valve: a single center
experience with two cases

Know MoreThe Egyptian Heart Journal (2024)(2024) 2 Patients -- Oyewole A. Kushimo, Nigeria
OR 09

Prediction of Prosthetic Heart Valve Interaction During Transcatheter Double-Valve Replacement Using a Bench Model

Know MoreJournal of American College of Cardiology (2025)(2024) 3 Patients -- Dr Vasu Nandhakumar, India
OR 10

Prosthetic Heart Valve Interactions and Their Clinical Significance During Transcatheter Left-Sided Double Valve Replacement

Know MoreJournal of American College of Cardiology (2025)(2024) 3 Patients -- Dr Vasu Nandhakumar, India
Editorial/ Editorial Letters (11)
OR 01 (Intermediate) size mattersKnow MoreInternational Journal of Cardiology (2021)(2024) 1 Patient -- Won-Keun Kim, Germany
OR 02 Transcatheter Pulmonary Valve Replacement With 32-mm Balloon-Expandable Prosthesis: Another Strategy in Mildly Dilated RVOTKnow MoreJACC: Cardiovascular Interventions (2021)(2024) - -- Marco B. Ancona, Italy
OR 03 Transcarotid transcatheter aortic valve implantation with a novel balloon expandable Myval™ THV under the local anesthesiaKnow MoreJournal of Geriatric Cardiology (2022)(2024) 1 Patient -- Hüseyin Ayhan, Turkey
OR 04 Neocommissural/ Coronary Alignment with a Novel Balloon Expandable Transcatheter Aortic Valve First-in-Human ExperienceKnow MoreJACC: Cardiovascular Interventions (2023)(2024) 32 Patients -- Pruthvi C.Revaiah, Ireland
OR 05 Bicuspid aortic valve: one of the last remaining challenges for the percutaneous treatment of aortic valve diseaseKnow MoreRevista Española de Cardiología (2023)(2024) - -- Pilar Jimenez Quevedo, Spain
OR 06 Transcatheter aortic valve replacement for noncalcified aortic regurgitation. Where are we now?Know MoreREC: Inteventional Cardiology (2024)(2024) - -- Ignacio J. Amat Santos, Spain
OR 07 LANDMARK trial: Update in study protocolKnow MoreAmerican Heart Journal (2024)(2024) - -- Akihiro Tobe, Ireland
OR 08 Novel 35-mm Balloon-Expandable Transcatheter Aortic Valve ReplacementKnow MoreJACC: Cardiovascular Interventions (2024)(2024) - -- John Jose, India
OR 09 BASELINE trial: update in study designKnow MoreAmerican Heart Journal (2024)(2024) - Protocol update- Rutger-Jan Nuis, The Netherlands
OR 10

Glimpse Into the Hemodynamic Performance of Myval Series vs Sapien
3 Ultra Resilia

Know MoreStructural Heart (2024)(2024) - -- Akihiro Tobe, Ireland
OR 11

Win ratio analysis of the LANDMARK trial

Know MoreAmerican Heart Journal (2025)(2024) 768 patients Multi-center, randomized, open-label, non-inferiority trial30 Days (10 Year follow-up) Akihiro Tobe, Ireland
Case Images (2)
OR 01 The novel balloon-expandable Myval transcatheter heart valve: systematic review of aortic, mitral, tricuspidKnow MoreCanadian Journal of Cardiology (2024)(2024) 1 Patient -- Mariano Pellicano, Italy
OR 02

Transcatheter Aortic Valve in Failing Mechanical Aortic Valve

Know MoreJACC: Cardiovascular Interventions (2024)(2024) 1 Patient -- Mario García Gómez, Spain
Systematic Review (3)
OR 01 The novel balloon-expandable Myval transcatheter heart valve: systematic review of aortic, mitral, tricuspid and pulmonary indicationsKnow MoreRevista Española de Cardiología (2024)(2024) 74 Patients -- Mario Garcia Gomez, Spain
OR 02

A systematic review and meta-analysis of the hemodynamics and outcomes of the Myval balloon-expandable valve in patients with severe aortic stenosis and with aortic regurgitation

Know MoreIJC Heart & Vasculature (2025)(2024) 2,864 patients from 29 studies -2 Years Elfatih A. Hasabo
OR 03

Effectiveness and Safety of Myval Versus Other Transcatheter Valves in Patients Undergoing TAVI: A Meta‐Analysis

Know MoreCatheterization and Cardiovascular Interventions (2025)(2024) Seven studies involving 3106 patients -12 months Anastasios Apostolos, Greece
Review Articles (11)
OR 01 Current status of transcatheter aortic valve replacement in IndiaKnow MoreCardiovascular Diagnosis and Therapy (2019)(2024) - -- Puneet Gupta, India
OR 02 Myval transcatheter heart valve system in the treatment of severe symptomatic aortic stenosisKnow MoreFuture Cardiology (2020)(2024) - -- Samin K Sharma, USA
OR 03 Choice of transcatheter heart valve: should we select the device according to each patient’s characteristics or should it be “one valve fits all”?Know MoreAnnals of Translational Medicine (2020)(2024) - -- Matthias Renker, Germany
OR 04 An update on new generation transcatheter aortic valves and delivery systemsKnow MoreJournal of Clinical Medicine (2022)(2024) - -- Gloria Santangelo, Italy
OR 05 Prosthesis tailoring for Patients undergoing transcatheter aortic valve implantationKnow MoreJournal of Clinical Medicine (2023)(2024) - -- Pier Pasquale Leone, USA
OR 06 Myval: a novel transcatheter heart valve for the treatment of severe aortic stenosisKnow MoreInterventional Cardiology Review, Research, Resources (2023)(2024) - -- Ashok Seth, India
OR 07 A novel balloon-expandable transcatheter aortic valve bioprosthesis: Myval and Myval OctacorKnow MoreExpert Review of Cardiovascular Therapy (2024)(2024) - -- Carolina Montonati,Italy
OR 08

Myval Transcatheter Heart Valve: The Future of Transcatheter Valve
Replacement and Significance in Current Timeline

Know MoreJournal of Clinical Medicine (2024)(2024) - -- Teoman Kilic, Turkey
OR 09

Pediatric cardiac interventions: Innovations from India

Know MoreAnnals of Pediatric Cardiology (2024)(2024) - -- Mantoo Mohsin Raj, India
OR 10

Transcatheter Heart Valves—An Update on Types of Valves Available, Hardware Characteristics, and Patient Selection: An Indian Perspective

Know MoreIndian Journal of Clinical Cardiology (2024) (2024) - -- Anoop Agrawal, India
OR 11

Myval transcatheter aortic valve series: An innovation in transcatheter aortic valve implantation technology

Know MoreInterventional Cardiology (2024)(2024) - -- Teoman Kilic, Turkey
Scientific Letter (1)
OR 01 Balloon-expandable Myval transcatheter aortic valve implantation. First experience in SpainKnow MoreRevista Espanola de Cardiologia (2020)(2024) 2 Patients -Discharge Sandra Santos-Martınez, Spain
Scientific Report (1)
OR 01 Angulation and curvature of aortic landing zone affect implantation depth in transcatheter aortic valve implantationKnow MoreScientific Report (2024)(2024) 81 Implants Observational, retrospective and single-center registryIndex Procedure Riccardo Gorla, Italy
Study Protocols (3)
OR 01 Rationale and design of a randomized clinical trial comparing safety and efficacy of Myval transcatheter heart valve versus contemporary transcatheter heart valves in Patients with severe symptomatic aortic valve stenosis: The LANDMARK trialKnow MoreAmerican Heart Journal (2021)(2024) - Prospective, randomized, multi-national, multi-centre, open-label, non-inferiority trial- Hideyuki Kawashima, Ireland
OR 02 Randomized comparison of TAVI valves: The Compare-TAVI trialKnow MoreAmerican Heart Journal (2024)(2024) - RCT- Christian Juhl Terkelsen, Denmark
OR 03

LANDMARK trial: Update in statistical analytical plan and protocol for the one-year report

Know MoreAmerican Heart Journal (2025)(2024) - Prospective, randomized, multi-national, multi-centre, open-label, non-inferiority triaProtocol update Akihiro Tobe, Ireland
Comment (3)
OR 01 New-generation Myval transcatheter heart valve in severe aortic stenosisKnow MoreTHE LANCET (2024)(2024) 384 Patients RCT30 Days Mariama Akodad, France
OR 02 Myval Balloon-Expandable Prosthesis in Argentina: Time to Take the Bull by the HornsKnow MoreRevista Argentina de Cardioangiología Intervencionista (2024)(2024) 300 Patients Prospective multi-center registryPost-procedure Federico Blanco, Argentina
OR 03

Head-to-head comparison of balloon-expandable transcatheter heart
valves

Know MoreTHE LANCET (2025)(2024) 514 out of 1031 Patients Multicentre, all-comers, randomised, non-inferiority trial1 Year Mariama Akodad France
ORTHOPEDIC (Total = 19 articles)
Freedom® Total Knee System (Total = 19 articles)
Original Research Articles (15)
OR 01

Restoration of femoral condylar anatomy for achieving optimum functional expectations: component
design and early results

Know MoreReconstructive review (2016)(2024) 172 Patients Prospective, non-randomized, single-center study2 Years with average follow-up of 3.8 ± 0.9 Years Sridhar Durbhakula, India
OR 02

Clinical evaluation of efficacy and performance of all-poly tibial Freedom® total knee system for treating osteoarthritis Patients: three-year follow up study

Know MoreJournal of Clinical and Diagnostic Research (2017)(2024) 158 Patients Retrospective, post-marketing study, single-center3 Years Avatar Singh, India
OR 03

Restoration of femoral condylar anatomy for achieving optimum functional expectations: continuation of an earlier study at 5-year minimum follow-up

Know MoreReconstructive review (2019)(2024) 172 Patients Prospective, single-center study5 Years Sridhar Durbhakula, India
OR 04

Education, engagement, and provision of empathy by trained counselor enhances the patient satisfaction after
total knee arthroplasty

Know MoreJournal of Clinical Orthopaedics and Trauma (2020)(2024) 200 Patients Prospective, randomized study52 Weeks Sanjay Bhalchandra Londhe, India
OR 05

Early results of bone‑conserving high flexion posterior‑stabilized total knee system in Indian population

Know MoreIndian Journal of Orthopaedics (2022)(2024) 208 Patients Prospective, continuous series study5 Years Average follow-up (years): 7.15 ± 1.23 (n = 208) Sanjay Bhalchandra Londhe, India
OR 06

Efficacy of the pre‑operative three‑dimensional (3D) CT scan templating in predicting accurate implant size and alignment in robot 

Know MoreIndian Journal of Orthopaedics (2022)(2024) 30 Patients Prospective, single-center study- Sanjay Bhalchandra Londhe, India
OR 07

A multi-centre retrospective study of the impact of body mass index on clinical and functional outcomes of total knee arthroplasty: An Indian prospective

Know MoreJournal of Orthopaedic Reports (2024)(2024) 259 Patients Multi-centre retrospective analysis3 Years Kunal Arneja, India
OR 08

Age wise comparative analysis of Patients undergoing total knee arthroplasty: a multicenter indigenous experience

Know MoreInternational Journal of Research in Orthopaedics (2024)(2024) 300 Patients Prospective, multi-centre, real-world study3 Years Ravi Teja Rudraraju, India
OR 09

A comprehensive comparative study on mid-term clinical and functional outcomes in Indian patients following bilateral total knee arthroplasty: assessing the impact of body mass index on post-total knee arthroplasty results

Know MoreInternational Journal of Research in Orthopaedics (2024)(2024) 190 Patients Prospective, multi-center observational study3 Years Karineravanda M. Ponnanna, India
OR 10

Comparison of Early Results Between Bone-Conserving
and Conventional High-Flexion Posterior-Stabilized Total Knee Arthroplasty

Know MoreJournal of Orthopedic Research and Therapy (2024)(2024) 280 Patients in Freedom TKA group Prospective studyMean follow up of 3.5 years (range, 2 to 5 years) Young-Hoo Kim, Republic of Korea
OR 11

Comparative mid-term evaluation of unilateral and bilateral total knee arthroplasty utilizing metal-backed
components: An assessment of functional and clinical outcomes (FREEDOM 400)

Know MoreJournal of Orthopaedic Reports (2025)(2024) 408 Patients Prospective, single-arm post-marketing surveillance study3 Years Ponnanna Karineravanda Machaiah, India
OR 12

Continuation of a Currently Available Primary Total Knee Arthroplasty System Design: 10-Year Follow-Up of Earlier Studies at 2- and 5-Years

Know MoreJournal of Orthopaedic Experience & Innovation (2024)(2024) 172 Patients Prospective study 10 Years Sridhar Durbhakula, India,
OR 13

Evaluation of the safety and efficacy of the fully automated active robotic system in robotic-assisted total knee arthroplasty

Know MoreJournal of Clinical Orthopaedics and Trauma (2023)(2024) 30 Patients Single-center, prospective study6 Months Sanjay Bhalchandra Londhe, India
OR 14

An Early Experience with a Novel Technique of Total Knee
Arthroplasty for Osteoarthritic Knee with Coexistent Traumatic Tibia Diaphysis Fracture

Know MoreIndian Journal of Orthopaedics (2022)(2024) 3 Patients Retrospective analysis2 Years Sanjay Bhalchandra Londhe, India
OR 15

Mid-term Outcomes of Patella Resurfacing During Total Knee Arthroplasty (TKA): Clinical, Functional, and Radiographic Insights 

Know MoreCureus (2024)(2024) 74 Patients Prospective, multicenter, single-arm, real-world study3 Years Supreet Bajwa, India
Commentary (1)
OR 01

Challenges in successful management of haemophilic knee arthropathy: our experience in a tertiary center

Know MoreJournal of Orthopaedics (2022)(2024) 24 Patients Retrospective chart review1 Year Mohan Thadia, India
Abstract (3)
OR 01

One-stage total knee arthroplasty with long stemmed tibia for traumatic tibial diaphysis fracture with co-existing osteoarthritis of the knee

Know MoreOrthopaedics Proceedings (2022)(2024) 3 Patients -1 Year Sanjay Bhalchandra Londhe, India
OR 02

Component size discrepancies and their influence on three-year outcomes in simultaneous bilateral total knee arthroplasty: A multicentral prospective study

Know MoreJournal of Clinical Orthopaedics and Trauma (2024)(2024) 166 Patients Multicenter , Prospective Study3 years Kunal Aneja, India
OR 03

Can the subvastus approach for total knee arthroplasty help in achieving high flexion in highflex knees? Results of 242 knees at four years

Know MoreOrthopaedic Proceedings (2019)(2024) 184 Patients Retrospective, observational, real-world studyMean follow-up 3.71 ± 0.98 Years Nilen Shah, India
ENDOSURGERY (Total = 14 articles)
MERIZELLE Absorbable Hemostat- Clinical Publication (Total = 1 articles)
Original Research Articles (1)
OR 01

The Safety and Effectiveness of MERIZELLE Oxidized Regenerated Cellulose in Achieving Hemostasis Across Various Surgical Procedures-A Prospective, Multi-Center, Post-Marketing Surveillance Study

Know MoreJournal of Wound Care (2024)(2024) 189 Patients Prospective, Multi-Center, Post-Marketing Surveillance Study 6 Months Amey Patankar, India
MITSU™ ABP Polyglactin 910 Suture-Clinical Publications (Total = 2 articles)
Study Protocol (1)
OR 01

Evaluation of safety and efficacy of Polyglactin 910 suture in surgical incision closure: clinical study protocol for a randomized controlled trial

Know MoreInternational Journal of Clinical Trials (2018)(2024) 122 Patients Prospective, multi-center, randomized, controlled, comparative, post-marketing and single-blinded6 Months Asha Dixit, India
Original Research Articles (1)
OR 01

Safety and Efficacy of triclosan-coated polyglactin 910 suture in prevention of surgical site infection in postpartum women: A randomized controlled trial

Know MoreJournal of the Indian Medical Association (2018) (2024) 122 patients Prospective, multicenter, single-blinded (Patient blinded), randomized controlled trial6 Months Asha Dixit, India
MIRUS™ Disposable Haemorrhoids Stapler- Clinical Publications (Total = 2 articles)
Original Research Articles (2)
OR 01

Comparison of conventional (CH) vs stapled haemorrhoidectomy (SH): three-yearss experience

Know MoreAnnals of International Medical and Dental Research (2017)(2024) 150 Patients Retrospective and comparative study1 Year Kumar Gaurav, India
OR 02

Clinical outcomes of stapled hemorrhoidopexy using a novel three-row stapler for grade III/IV hemorrhoids: A single-center experience with literature review

Know MoreJournal of Clinical Images and Medical Case Reports (2023)(2024) 77 Patients Retrospective single centre, cohort study2 Years M Sadiq Kazi, India
Mirus™ Circular Stapler- Clinical Publications (Total = 3 articles)
Original Research Article (2)
OR 01

Our initial experience of three versus two rows circular stapler devices for stapled hemorrhoidopexy: a single institution review of 224 cases

Know MoreInternational Surgery Journal (2020)(2024) 224 Patients Retrospective, observational, cohort study- Paritosh Gupta, India
OR 02

Clinical outcomes of stapled hemorrhoidopexy using a novel three-row stapler for grade III/IV hemorrhoids: A single-center experience with literature review

Know MoreJournal of Clinical Images and Medical Case Reports (2023)(2024) 77 patients A single centre study2 years M Sadiq Kazi, India
Study Protocol Clinical Trial (1)
OR 01

Uni-center, patient-blinded, randomized, 12-month, parallel group, non-inferiority study to compare outcomes of 3-row vs 2-row circular staplers for colorectal anastomosis formation after low anterior resection for rectal cancer

Know MoreMedicine (2019)(2024) 154 Patients Prospective, non-inferiority, 2-armed, parallel-group- Nikita A. Nekliudov, Russia
Fiona™ Intrauterine Contraceptive Device-Clinical Publication (Total = 1 articles)
Original Research Article (1)
OR 01

Safety and performance of a levonorgestrel-releasing intrauterine contraceptive device: one-year outcomes of Fiona-1 clinical registry

Know MoreJournal of the Indian Medical Association (2019)(2024) 309 Patients Prospective, open-label, single-arm post-marketing study1 Year Jagruti Desai, India
FILASILK™ Silk Suture-Clinical Publication (Total = 1 articles)
Original Research Article (1)
OR 01

The safety and efficacy of clipless versus conventional laparoscopic cholecystectomy-our experience in an Indian rural center

Know MoreMAEDICA Journal of Clinical Medicine (2018)(2024) 160 Patients Prospective study2 Months Rikki Singal, India
MEGASORB™ Polyglycolic Acid Suture-Clinical Publication (Total = 1 articles)
Original Research Article (1)
OR 01

Comparative evaluation of two antibacterial-coated resorbable sutures versus non coated resorbable sutures in periodontal flap surgery: A clinico-microbiological study

Know MoreIndian Society of Periodontology (2019)(2024) Total 30 Patients. 10 patients with each suture Randomized controlled double-blinded study1 Month Prerna Ashok Karde, India
MEGASORBPLUS™ Polyglycolic Acid Suture with Chlorhexidine-Clinical Publication (Total = 1 articles)
Original Research Article (1)
OR 01

Comparative evaluation of two antibacterial-coated resorbable sutures versus non coated resorbable sutures in periodontal flap surgery: A clinico-microbiological study

Know MoreIndian Society of Periodontology (2019)(2024) 10 out of 30 Patients Randomized controlled double-blinded study1 Month Prerna Ashok Karde, India
MEGASORB RAPID™ Polyglycolic Acid Suture-Clinical Publication (Total = 1 articles)
Original Research Article (1)
OR 01

Comparative evaluation of two antibacterial-coated resorbable sutures versus non coated resorbable sutures in periodontal flap surgery: A clinico-microbiological study

Know MoreIndian Society of Periodontology (2019)(2024) 10 out of 30 Patients Randomized controlled double-blinded study1 Month Prerna Ashok Karde, India
ABSOMESH™ Polyglecaprone 25/ Polypropylene Mesh-Clinical Publication (Total = 1 articles)
Original Research Article (1)
OR 01

A comparative study of open vs laparoscopic repair in umbilical and para umbilical hernias

Know MoreJournal of Dental and Medical Sciences (2019)(2024) 70 out of 156 Patients Prospective, observational studyPost-operative P. Venkata Buddha, India

Explore More

Clinical Publications

Arrow Icon

Clinical Programs

Arrow Icon

Doctors Speak

Arrow Icon